Toggle Main Menu Toggle Search


Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

Lookup NU author(s): Dr David Jamieson, Dr Nicola Cresti, Julieann Sludden, Melanie Griffin, Nahed Hawsawi, Emily Mould, Dr Mark Verrill, Dr Felicity May, Professor Alan Boddy


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EVA, Verrill MW, May FEB, Boddy AV

Publication type: Article

Journal: Pharmacogenetics and Genomics

Year: 2011

Volume: 21

Issue: 12

Pages: 808-819

Print publication date: 01/12/2011

ISSN (print): 1744-6872

ISSN (electronic): 1744-6880

Publisher: Lippincott Williams & Wilkins


DOI: 10.1097/FPC.0b013e32834b6918


Altmetrics provided by Altmetric


    Link to this publication